A recent warning letter reiterates the importance of collecting adverse event reports in order to demonstrate full compliance with federal laws governing the manufacture and sale of dietary supplements.
The US Food and Drug Administration says it will move actively to prevent the worldwide trade in dietary ingredients, food ingredients and whole foods from being restricted because of misplaced coronavirus infection concerns.
With the regulatory path forward for hemp-derived CBD in foods and supplements no clearer a year after the FDA’s May 2019 public meeting, trade association The Council for Responsible Nutrition (CRN) has filed a citizen’s petition urging the FDA to regulate...
A US Food and Drug Administration study reveals that a number of the products it tested labeled as ‘bitter orange’ did not meet label claim for synephrine content and more than 10% contained undeclared synthetic ingredients.
The prevalence of virus-treatment claims in the marketplace has made for both heightened enforcement from federal regulators and calls for even more action from an advocacy group regarding products sold on Amazon.
The Natural Products Association (NPA) is calling for the US Food and Drug Administration to use import alerts to stop nutritional supplements that fail to comply with New Dietary Ingredient (NDI) regulations.
A judge has approved a permanent injunction order against the principals of a dietary supplement company who allegedly repeatedly ignored FDA warnings and inspection findings on illegal disease claims and other violations.
The National Advertising Division has ruled that GSK must stop calling some of its Benefiber prebiotic supplements ‘100% natural.’ It’s a ruling that could be viewed as troublesome for other prebiotic ingredients.
A new stakeholder group has come together to push for quality and transparency in the dietary supplement industry. Called the Dietary Supplement Quality Collaborative (DSQC), the group published a policy paper recently as part of its public debut.
Both local Chinese and foreign infant nutrition brands in China are urged to “push hard on safety cues and messages” in light of the recent infant nutrition scandal happening in the country, according to an industry expert.